Profiling protective antibody responses against infectious diseases

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA475920

Grant search

Key facts

  • Disease

    COVID-19, Unspecified
  • Start & end year

    2027.0
    2031.0
  • Known Financial Commitments (USD)

    $1,864,781.77
  • Funder

    National Health and Medical Research Council (NHMRC)
  • Principal Investigator

    .
  • Research Location

    Australia
  • Lead Research Institution

    University of Melbourne
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Antibodies are a vital component of the immune response required for protection and control of infectious diseases. My research program will determine how antibodies contribute to protection and control of some of the world’s most deadly infectious pathogens (COVID-19, Influenza, Malaria and Mycobacterium Tuberculosis) in order to develop improved antibody-based vaccines, therapies and diagnostic tools.